Tengion (TNGN) Files $40.25M IPO

December 28, 2009 8:59 AM EST Send to a Friend
Get Alerts TNGN Hot Sheet
Trade TNGN Now!
Join SI Premium – FREE
Tengion (Nasdaq: TNGN) filed a registration statement with the SEC for an initial public offering of its common stock. The proposed maximum aggregate offering price is $40.25 million. The company plans to list on the NASDAQ under the stock symbol "TNGN".

The offering is being made through Piper Jaffray.

Tengion is a regenerative medicine company focused on discovering, developing, manufacturing and commercializing a range of replacement organs and tissues, or neo-organs and neo-tissues.

You May Also Be Interested In





Related Categories

IPOs

Related Entities

Piper Jaffray

Add Your Comment